A stepwise approach to management of stable COPD with inhaled pharmacotherapy: A review

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.

Original languageEnglish (US)
Pages (from-to)1058-1081
Number of pages24
JournalRespiratory care
Issue number8
StatePublished - Aug 2009


  • Anticholinergics
  • COPD
  • Chronic obstructive pulmonary disease
  • GOLD
  • Global Initiative for Chronic Obstructive Lung Disease
  • Guidelines
  • Inhalation pharmacotherapy
  • β adrenergics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'A stepwise approach to management of stable COPD with inhaled pharmacotherapy: A review'. Together they form a unique fingerprint.

Cite this